spacer
home > ebr > winter 2001 > seeking competitive intelligence from patents
PUBLICATIONS
European Biopharmaceutical Review

Seeking Competitive Intelligence from Patents

The Nature of Patents

'Patents are the lifeblood of the pharmaceutical industry' is a statement which acquired cliché status long ago, but which is undeniably true. When the statement was first uttered, probably more than 40 years ago, the orator was surely thinking in terms of the innovations which characterised the mid-20th Century - such drug classes as the b-lactam antibacterials, the b-blockers, the non-steroidal anti-inflammatories and so on. Now that biotechnology has changed the drug discovery landscape forever, the cliché remains equally valid: the drug industry depends on innovation, and innovation calls for a strong and effective patent system.

A patent is a bargain. The inventor makes a full disclosure of the innovation, and in return the State grants a monopoly for a limited period. Though it is the first of these concepts that forms the focus of this article, it is worthwhile reflecting briefly on the second. Not all industries make such comprehensive use of the patent system as the pharmaceutical industry does, and this must be a consequence of the similarity between the life cycle of a successful pharmaceutical product and the 20-year patent term which is now practically universal.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Peter Steele, Managing Director at Current Patents Ltd

Peter Steele graduated in Chemistry and then studied Information Science. He worked in industrial information departments for more than 20 years, including 16 years as head of Glaxo's intellectual property information unit based in London.
Seven years as an Independent IP Consultant ended in 1998 when he joined Current Science Group in order to establish Current Patents Ltd.

spacer
Peter Steele
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Productive Networking Of Pharmaceutical Leaders At PHARMAP 2022

Connecting innovators in the pharmaceutical industry and contributing to further development of ongoing pharmaceutical trends were the main directions of PHARMAP 2022. The Congress gathered pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies to exchange experience in digital transformation and discuss innovative solutions and business practices. The Congress was held on June, 20-21, 2022 in Berlin, Germany.
More info >>

White Papers

Streamlining patient recruitment using EHR data

The field of (bio)pharmaceutical research is booming. Increasingly more innovative therapeutics are being developed with the ability to drastically improve the quality of life of millions of patients around the world. Rigorously testing each of these candidate drugs for their safety and efficacy is an essential part of the development process. As the number of clinical trials steadily increases, the search for patients who present a specific medical profile and are willing to participate intensifies.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement